相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo
James E. Dowling et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies
Valentina Salizzato et al.
ONCOTARGET (2016)
A Note of Caution on the Role of Halogen Bonds for Protein Kinase/Inhibitor Recognition Suggested by High- And Low-Salt CK2α Complex Structures
Barbara Guerra et al.
ACS CHEMICAL BIOLOGY (2015)
Proteomics perturbations promoted by the protein kinase CK2 inhibitor quinalizarin
Cinzia Franchin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Identification of a novel potent, selective and cell permeable inhibitor of protein kinase CK2 from the NIH/NCI Diversity Set Library
Barbara Guerra et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer
Harsh B. Pathak et al.
PLOS ONE (2015)
Conformational Flexibility of Human Casein Kinase Catalytic Subunit Explored by Metadynamics
Aurelie Gouron et al.
BIOPHYSICAL JOURNAL (2014)
Phosphoproteomics of MAPK Inhibition in BRAF-Mutated Cells and a Role for the Lethal Synergism of Dual BRAF and CK2 Inhibition
Robert Parker et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Activity-based kinase profiling of approved tyrosine kinase inhibitors
Daisuke Kitagawa et al.
GENES TO CELLS (2013)
Crystal structure of human CK2α at 1.06 Å resolution
Takayoshi Kinoshita et al.
JOURNAL OF SYNCHROTRON RADIATION (2013)
CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway
R. C. Prins et al.
LEUKEMIA (2013)
TF - A novel cell-permeable and selective inhibitor of human protein kinase CK2 induces apoptosis in the prostate cancer cell line LNCaP
Claudia Goetz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Protein kinase CK2 inhibitors: a patent review
Giorgio Cozza et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy
Adam Siddiqui-Jain et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Effects of the CK2 Inhibitors CX-4945 and CX-5011 on Drug-Resistant Cells
Sofia Zanin et al.
PLOS ONE (2012)
Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer
Roberto Battistutta et al.
BIOCHEMISTRY (2011)
Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer
Fabrice Pierre et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Structural and functional determinants of protein kinase CK2α: facts and open questions
Roberto Battistutta et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis et al.
NATURE BIOTECHNOLOGY (2011)
Addiction to protein kinase CK2: A common denominator of diverse cancer cells?
Maria Ruzzene et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design
Karsten Niefind et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Emergence of protein kinase CK2 as a key target in cancer therapy
Janeen H. Trembley et al.
BIOFACTORS (2010)
Protein kinase CK2: From structures to insights
K. Niefind et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
First Inactive Conformation of CK2α, the Catalytic Subunit of Protein Kinase CK2
Jennifer Raaf et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Targeting cancer with small molecule kinase inhibitors
Jianming Zhang et al.
NATURE REVIEWS CANCER (2009)
Prodrugs: design and clinical applications
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Gini coefficient: A new way to express selectivity of kinase inhibitors against a family of kinases
Piotr P. Graczyk
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level
G. Di Maira et al.
ONCOGENE (2007)
Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: Challenges to the discovery scientist
K Beaumont et al.
CURRENT DRUG METABOLISM (2003)
One-thousand-and-one substrates of protein kinase CK2?
F Meggio et al.
FASEB JOURNAL (2003)
Protein kinase CK2: structure, regulation and role in cellular decisions of life and death
DW Litchfield
BIOCHEMICAL JOURNAL (2003)
分享论文
